Specify a stock or a cryptocurrency in the search bar to get a summary
Shattuck Labs Inc
STTKShattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas. Address: 500 West 5th Street, Austin, TX, United States, 78701
Analytics
WallStreet Target Price
2 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures STTK
Dividend Analytics STTK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History STTK
Stock Valuation STTK
Financials STTK
Results | 2019 | Dynamics |